The pharmaceutical landscape is currently witnessing a tectonic shift. As we move away from traditional “one-size-fits-all” small molecules toward complex biologics and genetic medicines, the primary bottleneck is no longer just discovering a potent therapeutic—it is delivering it safely and effectively to the right cell.
Lipid-based drug delivery systems (LBDDS) have...